Subscribe today to receive CGD’s latest newsletters and topic updates.
Gavi Needs a New Playbook to Deliver Impact in a Changing World
January 30, 2024
Since its launch in 2000, Gavi, the Vaccine Alliance, has leveraged three primary levers to expand equitable vaccine access in lower-income countries. First, Gavi supports introductions of new and underused vaccines. Second, Gavi helps scale equitable immunization coverage rates. Third, Gavi uses an...
From Decision to Action: The Africa Epidemics Fund
January 10, 2024
This blog outlines key considerations regarding how the AEF raises and spends funds, underscoring the significance of a robust design and effective implementation at a time when the AEF’s proposed governance and operational mechanisms are being deliberated on and presented to the AU policy organs fo...
Measuring the Quality of Hospital Care—a Pragmatic Approach
December 14, 2023
The low quality of health care services has become a primary concern globally and for low- and middle-income countries (LMICs) that have made bold commitments to progress toward universal health coverage. Despite improvements, an estimated five million deaths could be averted globally through better...
Deciding the Fate of Billions: What’s Next for Gavi’s Unspent COVAX Funds?
December 04, 2023
In the aftermath of the COVID-19 pandemic, Gavi faces an unprecedented situation. Billions of dollars that it raised back in 2022 for COVAX—the global effort to provide COVID-19 vaccines to lower-income countries—remain unspent. These resources are substantial, exceeding the entire annual budget of ...
Gavi 6.0: A New Era for Global Immunization
December 01, 2023
When Gavi’s board meets in Accra, Ghana, next week, advancing discussions on a new five-year strategic period, known as “Gavi 6.0,” will be a top agenda item. But conversations about Gavi’s future direction are also taking place against the backdrop of a leadership transition and a rapidly changing ...
The Role of Regulation in Advancing African Vaccine Manufacturing: Policy Options for Gavi
November 29, 2023
Regulation plays a vital role in ensuring the quality, safety, and efficacy of vaccines—and a strong regulatory system is key to successfully expanding vaccine manufacturing. The Gavi Secretariat is currently fine-tuning the design of a new Advance Market Commitment (AMC)—a financial mechanism to su...
Accelerating Vaccine Manufacturing in Africa: Three Considerations for Gavi
November 15, 2023
One of the most salient lessons from the pandemic is the need to diversify manufacturing capabilities and bolster supply resilience to avoid a repeat of the slow and inequitable vaccine roll out in African countries. To turn this lesson into action, the Gavi Secretariat is rapidly advancing plans fo...